Careers  |  Sign In  |  Register

Low-Cost Combination Therapy Shows Promise for Slowing HIV Progression

Bloomberg News reports on a study in JAMA that has shown that a simple and cost-effective treatment may slow the progress of HIV progression and the development of AIDS. The study followed 878 HIV-infected patients in Botswana who were given either a dose of vitamins B,C, and E, a dose of selenium, or a combination therapy of both the vitamins and selenium. None of the patients had taken antiretroviral medications. Results showed that patients who received the combination therapy of vitamins and selenium had a 54% reduced risk of reaching a CD4 cell count so low they would require antiretroviral medication. The findings “will be helpful to patients without costing a whole lot of money and needing a complicated infrastructure of laboratories and pharmacies.”

Read the article published by Bloomberg News.

Read the study in JAMA.